In conclusion, this study significantly enhances the understanding of MYCN-amplified retinoblastoma by establishing a robust, human-specific modeling platform—encompassing retinal organoids, derived cell lines, and orthotopic xenografts. This evidence concerns the gene MYCN and retinoblastoma.